PARTNERSHIPS
Clinically validated cardiac monitoring — built for population-scale deployment
FibriCheck gives health plans, RPM platforms, and digital health organizations a device-free, FDA-cleared solution to detect and monitor atrial fibrillation across their entire member population — without adding operational complexity.

Clinical accuracy on par with leading ECG solutions
FDA-cleared and validated across 100+ peer-reviewed publications — a regulated medical device, not a wellness app.
Demonstrated ROI at population scale
Deployed across 25,000+ members with one insurance partner — measurable impact on detection, avoidable costs, and engagement.
No hardware. No logistics. No shipment.
Members use their own smartphone. Scales from hundreds to hundreds of thousands with zero device overhead.
Atrial fibrillation is undertreated at every stage of the care pathway
1 in 3
adults will develop AF in their lifetime
Most cases are clinically silent — undetected until a stroke or cardiac event occurs.
85%+
of unnecessary referrals and diagnostics can be avoided
Early rhythm correlation between symptoms and ECG findings reduces unnecessary downstream cost.
<20%
of diagnosed AF patients receive continuous monitoring
Yet AF is a chronic, recurring condition — gaps between visits are where serious events happen.
Sources: Calvert et al, EHJ DH 2024. Real-world evidence. Data on file.
Early detection doesn't just save lives — it reduces stroke costs, avoids unnecessary diagnostics, and enables your organization to manage AF as the chronic condition it is.
Who we work with
FibriCheck is designed to integrate into existing care ecosystems — not replace them. scalability.
Health Plans & Insurers
High AF-related stroke costs and undetected members
Deploy FibriCheck as a member benefit to detect undiagnosed AF before it becomes a stroke or heart failure event. Scalable across your full at-risk population — no device logistics, no hardware cost.
RPM & Care Management Platforms
Need a validated cardiac module to add to your suite
Add clinically validated cardiac rhythm monitoring to your existing platform. FibriCheck integrates via API, supports RPM reimbursement, and brings 100+ peer-reviewed publications of clinical credibility.
Health Tech Companies
Population health platforms looking to add validated cardiac capability
Embed medical-grade AF detection into your population health or patient engagement solution. FibriCheck is FDA-cleared, CE-marked, and deployable as an embeddable component — purpose-built for care gap, chronic disease, and preventive health programs.
Employer Wellness Programs
AF risk in workforce driving absenteeism and disability claims
Offer proactive cardiac screening as part of your employee health benefit. FibriCheck detects AF at scale across your workforce — supporting preventive care commitments and reducing long-term health costs.
THE NUMBERS
Real-world numbers from live deployments
In our largest insurance deployment, 25,000+ members were monitored. Here's what population-scale cardiac monitoring revealed.
25,000+
Members monitored
11,000+
Reported cardiac symptoms
615
AF detected in symptomatic members
450
Silent AF discoverd - no prior suspicion
>90%
Compliance across all demographics
95%
Reduction of un-necessary consultations
Loomer Medical Group, NHS Staffordshire, Stoke-on-Trent
5x
Higher detection yield vs traditional screening
NHS Barking, Havering and Redbridge University Hospital
50%
Reduction in time and healthcare utilization costs
Maastricht UMC, HRS Mid and South Essex
INTEGRATION
Ready to evaluate the integration?
Whether you're assessing API compatibility, compliance requirements, or deployment architecture — our Integration Guide walks you through how FibriCheck connects to your infrastructure.
Covers: API architecture, FHIR compatibility, SSO and identity management, data governance, reporting, and compliance documentation.
Ready to bring FibriCheck to your population?
Connect with our partnerships team to explore how FibriCheck can integrate into your organization's cardiac care strategy.












